Patents by Inventor Hitomi OZAWA

Hitomi OZAWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug composition for parenteral administration
    Patent number: 11986530
    Abstract: Provided is a curcumin pharmaceutical preparation that is highly water soluble, can maintain the concentration of free curcumin in the blood sufficiently high by being administered parenterally, can effectively obtain a pharmacological action of curcumin, and is highly safe. A pharmaceutical composition for parenteral administration, including a water-soluble substance conjugate of curcumin as an active component.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: May 21, 2024
    Assignees: THERABIOPHARMA INC., KYOTO UNIVERSITY
    Inventors: Hideaki Kakeya, Masashi Kanai, Nobuaki Takahashi, Tadashi Hashimoto, Atsushi Imaizumi, Hitomi Ozawa
  • DRUG COMPOSITION FOR PARENTERAL ADMINISTRATION
    Publication number: 20200254105
    Abstract: Provided is a curcumin pharmaceutical preparation that is highly water soluble, can maintain the concentration of free curcumin in the blood sufficiently high by being administered parenterally, can effectively obtain a pharmacological action of curcumin, and is highly safe. A pharmaceutical composition for parenteral administration, including a water-soluble substance conjugate of curcumin as an active component.
    Type: Application
    Filed: April 27, 2020
    Publication date: August 13, 2020
    Applicants: THERABIOPHARMA INC., KYOTO UNIVERSITY
    Inventors: Hideaki KAKEYA, Masashi Kanai, Nobuaki Takahashi, Tadashi Hashimoto, Atsushi Imaizumi, Hitomi Ozawa
  • DRUG COMPOSITION FOR PARENTERAL ADMINISTRATION
    Publication number: 20190224325
    Abstract: Provided is a curcumin pharmaceutical preparation that is highly water soluble, can maintain the concentration of free curcumin in the blood sufficiently high by being administered parenterally, can effectively obtain a pharmacological action of curcumin, and is highly safe. A pharmaceutical composition for parenteral administration, including a water-soluble substance conjugate of curcumin as an active component.
    Type: Application
    Filed: June 28, 2017
    Publication date: July 25, 2019
    Applicants: THERABIOPHARMA INC., KYOTO UNIVERSITY
    Inventors: Hideaki KAKEYA, Masashi KANAI, Nobuaki TAKAHASHI, Tadashi HASHIMOTO, Atsushi IMAIZUMI, Hitomi OZAWA
  • Composition for oral intake
    Patent number: 10245238
    Abstract: Provided is a composition for oral intake, which exhibits improved oral absorbability of curcumin and/or an analog thereof and can be produced conveniently and inexpensively. A complex of curcumin and/or an analog thereof and a water-soluble cellulose derivative is disclosed.
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: April 2, 2019
    Assignees: THERAVALUES CORPORATION
    Inventors: Hirofumi Takeuchi, Kohei Tahara, Atsushi Imaizumi, Tsukasa Takahashi, Takato Matsui, Hitomi Ozawa
  • COMPOSITION FOR ORAL INTAKE
    Publication number: 20170239194
    Abstract: Provided is a composition for oral intake, which exhibits improved oral absorbability of curcumin and/or an analog thereof and can be produced conveniently and inexpensively. A complex of curcumin and/or an analog thereof and a water-soluble cellulose derivative is disclosed.
    Type: Application
    Filed: May 14, 2015
    Publication date: August 24, 2017
    Applicants: THERAVALUES CORPORATION
    Inventors: Hirofumi TAKEUCHI, Kohei TAHARA, Atsushi IMAIZUMI, Tsukasa TAKAHASHI, Takato MATSUI, Hitomi OZAWA